JNJ-8114
/ J&J
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
May 06, 2024
A Study of JNJ-80038114 in Participants With Advanced Stage Prostate Cancer
(clinicaltrials.gov)
- P1 | N=39 | Completed | Sponsor: Janssen Research & Development, LLC | Recruiting ➔ Completed | N=90 ➔ 39 | Trial completion date: Mar 2025 ➔ Mar 2024 | Trial primary completion date: Mar 2025 ➔ Mar 2024
Enrollment change • Metastases • Trial completion • Trial completion date • Trial primary completion date • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
January 18, 2023
A Study of JNJ-80038114 in Participants With Advanced Stage Prostate Cancer
(clinicaltrials.gov)
- P1 | N=90 | Recruiting | Sponsor: Janssen Research & Development, LLC | Trial completion date: Jun 2025 ➔ Mar 2025
Metastases • Trial completion date • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
November 23, 2022
A Study of JNJ-80038114 in Participants With Advanced Stage Prostate Cancer
(clinicaltrials.gov)
- P1 | N=110 | Recruiting | Sponsor: Janssen Research & Development, LLC | Not yet recruiting ➔ Recruiting | Trial completion date: Mar 2025 ➔ Jun 2025
Enrollment open • Trial completion date • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
July 01, 2022
A Study of JNJ-80038114 in Participants With Advanced Stage Prostate Cancer
(clinicaltrials.gov)
- P1 | N=110 | Not yet recruiting | Sponsor: Janssen Research & Development, LLC
New P1 trial • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
1 to 4
Of
4
Go to page
1